Why Is Mphasis Share Price Falling? Key Reasons & Share Price Target

Fri Apr 10 2026

Mphasis is trading at Rs 2,100, down 32% from its 52-week high of Rs 3,200. The sustained fall in the Mphasis share price has unsettled investors who built positions during the stock’s rally phase. At its current price, the stock is approaching its 52-week low of Rs 1,900, and the market is asking one question loudly: is this a buying opportunity, or is the decline a warning sign of deeper problems?

The Mphasis share price falling is not random. There are specific, identifiable factors driving institutional selling, retail panic, and analyst downgrades — and this article examines each of them with real data from the latest quarterly results and exchange filings.

[Click Here – Get Free Investment Predictions](https://univest.in/user/log-in)

This article covers every key reason behind the Mphasis share price fall, the latest financial performance data, technical levels to watch, institutional positioning, and what analysts think the Mphasis share price target is for 2026.

Table of Contents

About Mphasis

[Click Here – Get Free Investment Predictions on Univest.

Mphasis is a listed company in the Information Technology sector with a market capitalisation of Rs 39,300 Cr. The stock trades at approximately 22x trailing P/E and 4.8x price-to-book. Its 52-week range spans from Rs 1,900 to Rs 3,200, and the current price of Rs 2,100 puts the stock in the lower quarter of that range, reflecting the sustained selling pressure of recent months.

Why Is Mphasis Share Price Falling? Key Reasons

Mphasis Share Price Falling Key Data 2026

[Tap to Access Best Research Pieces on Univest.

DXC Technology Concentration Risk — Revenue Dependency

Mphasis derives approximately 27-30% of its revenue from DXC Technology, a single client dependency that has been a perennial concern for analysts. DXC itself has been under financial pressure for the past 2-3 years, with declining revenues and an active strategy of insourcing work previously outsourced to partners like Mphasis. Any material reduction in DXC-channelled revenue would have a disproportionate impact on Mphasis’s top line.

In Q3 FY26, direct channel revenue grew 15% YoY, but DXC-related revenue declined 3% YoY, creating a two-speed business dynamic that masks the true underlying growth of the company.

BFSI Slowdown — Core Vertical Under Pressure

Mphasis has historically derived 65-70% of its revenue from BFSI (Banking, Financial Services and Insurance) clients, primarily in the US and Europe. The global BFSI sector is undergoing a technology budget freeze as banks navigate the impact of interest rate normalisation, US regional bank stress from 2023 that has left balance sheet repair ongoing, and AI-driven re-evaluation of outsourcing models.

Deal wins in Q3 FY26 were stable but deal sizes have been smaller, with clients preferring pilot contracts over large multi-year commitments as they evaluate AI’s impact on their technology operating models.

IT Sector-Wide De-Rating Continues

Mphasis has been caught in the Nifty IT index decline that has taken the sector down 20%+ YTD. The macro concerns around AI disruption to IT services business models, US tariff uncertainty, and a potential slowdown in discretionary technology spending have all weighed on valuation multiples across the sector. Mphasis, being a mid-cap IT stock, has suffered more than its large-cap peers in the de-rating cycle.

Mphasis Latest News That Impacted the Stock

October 2025: Q2 FY26: Direct channel growth 18% YoY; DXC revenue down 2% YoY.

January 2026: Q3 FY26: Revenue Rs 3,912 Cr (+5.3% YoY); deal wins $235 million.

February 2026: Blackstone (controlling shareholder) reduces stake by 3%; triggers selling pressure.

March 2026: IT sector de-rating continues; Nifty IT index down 20% YTD.

April 2026: Mphasis Q4 FY26 results scheduled for second week of May.

Mphasis Financial Performance Analysis

The quarterly financial data for Mphasis provides important context for understanding why the share price is falling. The numbers below highlight the key metrics that institutional analysts track closely.

Key Metric	Latest Quarter	Year-Ago Quarter	YoY Change
Revenue	Rs 3,912 Cr	Rs 3,716 Cr	+5.3% YoY
Net Profit (PAT)	Rs 426 Cr	Rs 408 Cr	+4.4% YoY
Market Cap	Rs 39,300 Cr	—	Current
P/E Ratio	22x	—	Trailing
P/B Ratio	4.8x	—	Current

If you want to track Mphasis’s financial metrics in real time, check the Univest Screener for live data, peer comparisons, and financial history.

Technical Signals: What the Charts Are Saying

Mphasis is trading at Rs 2,100, below all key moving averages including the 50-day, 100-day, and 200-day MAs. The stock has formed a clear pattern of lower highs and lower lows since its 52-week high of Rs 3,200. Key support is at the 52-week low of Rs 1,900. Resistance is at Rs 2,100 in the near term.

Download the Univest iOS App or Univest Android App to track Mphasis’s live price and get daily research insights.

Market Sentiment and Institutional Positioning

Promoter holding stands at 55.5%, which provides some confidence in management commitment to the business. FII holding at 18.6% is moderate, and DII holding at 12.4% indicates domestic institutions have modest exposure.

High FII ownership in any stock creates downside amplification when global risk appetite contracts. The Mphasis share price falling has been exacerbated by FII selling that is driven by macro factors — crude oil, dollar strength, US rate expectations — rather than company-specific concerns alone.

Future Outlook: Can Mphasis Recover?

Mphasis’s fundamental story is sound at its core. The direct channel (70%+ of revenue) is growing at 15%+ and the client mix is diversifying. At Rs 2,100 and 22x P/E, Mphasis is trading at a discount to its 3-year average of 30-35x. The risk-reward is beginning to turn constructive. Blackstone’s stake reduction, while a near-term negative, is part of their fund exit cycle rather than a negative view on the business. Recovery catalysts: DXC channel stabilisation and a large deal win in the direct channel in Q4 FY26.

Mphasis Share Price Target 2026

Subscribe to Univest Pro for Premium Stock Research and F&O Setups.

Short-Term Target (3-6 Months)

In the short term, Mphasis share price target is Rs 2,100-2,350 based on current technical positioning and near-term fundamental catalysts. The downside risk if the 52-week low of Rs 1,900 breaks is approximately 5-10% further.

12-Month Analyst Target

Analyst consensus 12-month Mphasis share price target is Rs 2,600-3,000, implying significant upside from the current price of Rs 2,100. This target assumes a partial recovery of the factors driving the current decline.

Long-Term Target (FY27-FY28)

In a recovery scenario where the key headwinds resolve, the Mphasis share price target for FY28 is Rs 3,200-3,800. This long-term bull case requires the fundamental concerns addressed in this article to show measurable improvement over the next 6-12 quarters.

For live Mphasis tracking and peer comparison, explore the Univest Screener.

Conclusion

Mphasis share price is falling due to a combination of company-specific headwinds and broader market pressures. The 52-week decline of 32% from the high of Rs 3,200 to the current Rs 2,100 has created both a risk and an opportunity. The risk is that the concerns identified in this article deepen; the opportunity is that the stock is now meaningfully cheaper than it was at the peak. Analyst consensus targets of Rs 2,600-3,000 for 12 months and Rs 3,200-3,800 for the longer term suggest significant potential upside for patient investors.

This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.

Frequently Asked Questions

Q1. Why is Mphasis share price falling in 2026?

Mphasis share price is falling due to the reasons detailed in this article, including sector-specific headwinds, recent financial performance concerns, and broader market pressures. The stock has fallen 32% from its 52-week high of Rs 3,200 to its current price of Rs 2,100. Investors should review all factors and consult a SEBI-registered financial advisor before making investment decisions.

Q2. What is Mphasis share price target?

The 12-month analyst consensus Mphasis share price target is Rs 2,600-3,000. The short-term target for 3-6 months is Rs 2,100-2,350, while the long-term target for FY27-FY28 is Rs 3,200-3,800 in a recovery scenario. These are analyst projections and not guaranteed returns.

Q3. Should I buy Mphasis shares now?

This article cannot provide personalised investment advice. Mphasis is trading at Rs 2,100 with a 52-week range of Rs 1,900 to Rs 3,200. Analyst consensus targets suggest potential upside. However, all the risks outlined in this article remain live. Consult a SEBI-registered financial advisor for personalised advice.

Q4. What is Mphasis’s market cap and PE ratio?

Mphasis’s current market capitalisation is Rs 39,300 Cr with a trailing P/E of 22x and price-to-book ratio of 4.8x. The stock is trading at Rs 2,100 as of April 2026.

Q5. What are Mphasis’s latest quarterly results?

In the most recent quarter, Mphasis reported revenue of Rs 3,912 Cr (+5.3% YoY) and net profit (PAT) of Rs 426 Cr (+4.4% YoY). Full quarterly financial data is available on the NSE/BSE filing portals and on the Univest Screener.

Q6. Who holds Mphasis shares institutionally?

Mphasis’s shareholding: Promoters 55.5%, FIIs 18.6%, DIIs 12.4%. Check the latest quarter’s shareholding pattern on NSE/BSE for the most current data.

Q7. What can trigger a recovery in Mphasis share price?

Key recovery triggers for Mphasis include: improvement in the fundamental factors causing the current decline, positive quarterly results showing reversal of the stressed metrics, broad market recovery, and any sector-specific positive news. Monitor developments closely.

Q8. What is the 52-week low of Mphasis share price?

Mphasis’s 52-week low is Rs 1,900, reached during the recent market correction. The 52-week high was Rs 3,200. The current price of Rs 2,100 represents a fall of 32% from the 52-week high. Technical analysts identify Rs 1,900 as a key support level.

For more analysis on falling stocks, visit Univest Blogs.